Precision Health Informatics, LLC
The Gold Standard of Care with Advanced Health Data

Over the last decade, the explosion of new therapeutic treatments in cancer has been logarithmic, making it imperative for researchers and practicing oncologists to familiarize themselves with novel practices and offer better clinical judgments. Precision Health Informatics, LLC provides real-world data indicating treatment trends, financial and payor information and clinical outcomes for treating oncology patients. Leveraging one of the largest primary databases in the country, representing more than 1.6 million patients, it provides access to longitudinal data representing the oncology patient journey. This information can be utilized in extensive research efforts and accelerate innovation in cancer care.

Precision Health Informatics, LLC’s in-depth data combines all data resources, including a molecular data warehouse with over 400,000 unique patient molecular profiles. This helps identify the cancer’s root cause at the molecular level and pre-screen patients for clinical trials. Actionable tumor mutations identified through molecular profiling significantly enhance the outcome for an individual diagnosed with cancer when standard treatments offer little hope of a cure.

Keeping Pace with Real-World Treatment Response Data

Aggregating and analyzing critical healthcare information can lend real-time information on the efficacy of cancer drugs already on the market.

Precision Health Informatics, LLC is a crucial resource for drug developers, equipping them with vital information regarding innovative medicine. Streamlining access to data enables healthcare researchers and providers to make informed decisions, improve patient outcomes and change the cancer narrative from an acute to a chronic illness. Precision Health Informatics, LLC includes patient-reported outcomes (PRO) data for more than 45,000 unique patients.

We strive to provide the gold standard of care for our patients where they live, eliminating the need to travel extensively to academic centers to participate in clinical trials. Without compromising their care or eventual outcome, patients should be able to remain in their homes with the support of their family and friends. Our advanced data capabilities make this possible for the majority of our cancer patients

Enhancing Equity in Healthcare and Improving Access to Clinical Trials

Nearly two-thirds of all clinical trials require a biomarker analysis for a patient to participate, so having this information available to enrich clinical trials is equally important. Precision Health Informatics, LLC has more than 400,000 molecular profiles in its research database, updated daily. Each of these unique molecular profiles is matched to the patient’s medical record information, allowing researchers to match patient information to the inclusion criteria of their clinical trial.

“Along with our patient’s molecular profile, our data provides a complete picture of a patient’s medical records, including imaging and pathology records, and enables pharmaceutical and life science companies to create more effective and personalized medicine for all cancer patients,” says Lori Brisbin, chief operating officer.